Surgiphor 1,000mL allows clinicians to remove debris and microorganisms from wounds during powered irrigation procedures.
BD (Becton, Dickinson and Company) announced it has obtained CE Mark approval for the Revello vascular covered stent for the treat ...
BDX completes its Biosciences & Diagnostic spin-off and Waters merger, securing $4B in proceeds as it pivots to a pure-play ...
Zacks Investment Research on MSN
BDX secures CE mark for Revello stent to treat iliac artery disease
Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has received CE Mark approval in the European Union for its Revello Vascular Covered Stent. With this approval, BD ...
Waters Corp. and BD announced a definitive agreement July 14 to combine BD’s Biosciences & Diagnostic Solutions businesses with the Milford, Mass.-based company. The deal is structured as a ...
On February 5, 2025, Becton, Dickinson and Company (BD) announced plans to separate its Biosciences and Diagnostic Solutions business into an independent entity. The Biosciences and Diagnostic ...
After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results